Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
91M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$16M
-
Put/Call ratio
-
1.84
-
Number of buys
-
105
-
Number of sells
-
-89
-
Price
-
$13.36
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2018
257 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2018.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91M shares
of 106M outstanding shares and own 85.95% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.5M shares), FEDERATED INVESTORS INC /PA/ (11.6M shares), Vanguard Group Inc (10.8M shares), INGALLS & SNYDER LLC (8.37M shares), Consonance Capital Management LP (6.21M shares), RENAISSANCE TECHNOLOGIES LLC (4.65M shares), STATE STREET CORP (2.94M shares), Invesco Ltd. (2.19M shares), DIMENSIONAL FUND ADVISORS LP (1.9M shares), and MORGAN STANLEY (1.46M shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.